We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.55%
2 Healthcare 10.82%
3 Consumer Discretionary 9.19%
4 Financials 8.34%
5 Communication Services 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HGAS
4401
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
$11K ﹤0.01%
+1,117
New +$11.1K
OPGN
4402
DELISTED
OpGen, Inc
OPGN
$11K ﹤0.01%
99
+79
+395% +$8.61K
HHLA
4403
DELISTED
HH&L Acquisition Co.
HHLA
$11K ﹤0.01%
1,167
-5
-0.4% -$49
TBLT
4404
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$11K ﹤0.01%
79
+77
+3,850% +$55.5K
MCOM
4405
DELISTED
micromobility.com Inc. Class A Common stock
MCOM
$11K ﹤0.01%
+2
New +$21.6K
IMPL
4406
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$11K ﹤0.01%
1,210
-2,407
-67% -$17.6K
CEQP
4407
DELISTED
Crestwood Equity Partners LP
CEQP
$11K ﹤0.01%
464
-11,880
-96% -$342K
CYTO
4408
DELISTED
Altamira Therapeutics Ltd
CYTO
$11K ﹤0.01%
+57
New +$18.4K
INFI
4409
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$11K ﹤0.01%
17,237
+7,862
+84% +$6.04K
FORG
4410
DELISTED
ForgeRock, Inc.
FORG
$11K ﹤0.01%
+492
New +$9.67K
TCFC
4411
DELISTED
The Community Financial Corporation Common Stock
TCFC
$11K ﹤0.01%
293
+273
+1,365% +$10.3K
KVSC
4412
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$11K ﹤0.01%
1,100
+459
+72% +$4.48K
DGNU
4413
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$11K ﹤0.01%
1,121
+149
+15% +$1.46K
NAAC
4414
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
$11K ﹤0.01%
1,165
-2,016
-63% -$19.8K
MDH
4415
DELISTED
MDH Acquisition Corp.
MDH
$11K ﹤0.01%
1,111
-54
-5% -$529
MON
4416
DELISTED
Monument Circle Acquisition Corp. Class A Common Stock
MON
$11K ﹤0.01%
+1,141
New +$11.2K
GLHA
4417
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
$11K ﹤0.01%
1,086
-2
-0.2% -$20
VYGG
4418
DELISTED
Vy Global Growth
VYGG
$11K ﹤0.01%
1,057
+116
+12% +$1.15K
CDR
4419
DELISTED
Cedar Realty Trust, Inc
CDR
$11K ﹤0.01%
377
-747
-66% -$20.4K
BRPMU
4420
DELISTED
B. Riley Principal 150 Merger Corp. Unit
BRPMU
$11K ﹤0.01%
1,090
-100
-8% -$1K
AAME icon
4421
Atlantic American Corp
AAME
$30.2M
$10K ﹤0.01%
3,768
-829
-18% -$2.49K
ADVM
4422
DELISTED
Adverum Biotechnologies
ADVM
$10K ﹤0.01%
794
-2,810
-78% -$29.4K
AMTX icon
4423
Aemetis
AMTX
$126M
$10K ﹤0.01%
2,041
+423
+26% +$3.7K
APLT
4424
DELISTED
Applied Therapeutics
APLT
$10K ﹤0.01%
10,661
+4,799
+82% +$7.86K
ARBE icon
4425
Arbe Robotics
ARBE
$94.2M
$10K ﹤0.01%
1,862
+1,107
+147% +$7.52K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.